Bayer Buying Sagmel OTC Brands For Eastern European, Central Asian Boost
This article was originally published in The Tan Sheet
Executive Summary
Bayer will "substantially increase" its OTC presence in Russia and other countries in the Commonwealth of Independent States with its acquisition of U.S. firm Sagmel's drug and nutritional supplement brands, according to the firms